{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:57:16Z","timestamp":1772294236648,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf01831473","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T17:43:40Z","timestamp":1119980620000},"page":"29-41","source":"Crossref","is-referenced-by-count":25,"title":["Contraceptive steroids and the mammary gland: Is there a hazard?"],"prefix":"10.1007","volume":"23","author":[{"given":"GR","family":"Rutteman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01831473_CR1","first-page":"129","volume":"66","author":"HW Casey","year":"1979","unstructured":"Casey HW, Giles RC, Kwapien RP: Mammary neoplasia in animals. Pathologic aspects and the effect of contraceptive steroids. Rec Res Cancer Res 66:129\u2013160, 1979.","journal-title":"Rec Res Cancer Res"},{"key":"BF01831473_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0163-7258(79)90107-4","volume":"5","author":"MF Etreby El","year":"1979","unstructured":"El Etreby MF, Gr\u00e4f KJ: Effect of contraceptive steroids on mammary gland of female dog and its relevance to human carcinogenicity. Pharmac Ther 5:369\u2013402, 1979.","journal-title":"Pharmac Ther"},{"key":"BF01831473_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1185\/03007997609109324","volume":"4","author":"LN Owen","year":"1976","unstructured":"Owen LN, Briggs MH: Contraceptive steroid toxicology in the beagle dog and its relevance to human carcinogenicity. Curr Med Res Opin 4: 309\u2013329, 1976.","journal-title":"Curr Med Res Opin"},{"key":"BF01831473_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/019262338901700214","volume":"17","author":"BE McKenzie","year":"1989","unstructured":"McKenzie BE: Guidelines and requirements for the evaluation of contraceptive steroids. Toxicol Pathol 17:377\u2013384, 1989.","journal-title":"Toxicol Pathol"},{"key":"BF01831473_CR5","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/jama.1972.03190380029009","volume":"219","author":"LW Nelson","year":"1972","unstructured":"Nelson LW, Carlton WW, Weikel JHJ: Canine mammary neoplasms and progestogens. J Am Med Assoc 219:1601\u20131606, 1972.","journal-title":"J Am Med Assoc"},{"key":"BF01831473_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0024-3205(77)90507-0","volume":"21","author":"M Briggs","year":"1983","unstructured":"Briggs M: The beagle dog and contraceptive steroids. Life Sci 21:275\u2013284, 1983.","journal-title":"Life Sci"},{"key":"BF01831473_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/019262338901700216","volume":"17","author":"AN Johnson","year":"1989","unstructured":"Johnson AN: Comparative aspects of contraceptive steroids \u2014 Effects observed in beagle dogs. Toxicol Pathol 17:389\u2013395, 1989.","journal-title":"Toxicol Pathol"},{"key":"BF01831473_CR8","unstructured":"Anonymous: Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. Bull WHO 64:375\u2013382, 1986."},{"key":"BF01831473_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(16)59160-2","volume":"47","author":"GR Huggins","year":"1987","unstructured":"Huggins GR, Zucker PK: Oral contraceptives and neoplasia: 1987 update. Fert Steril 47:733\u2013761, 1987.","journal-title":"Fert Steril"},{"key":"BF01831473_CR10","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1001\/jama.1983.03330450052025","volume":"249","author":"A Rosenfield","year":"1983","unstructured":"Rosenfield A, Maine D, Rochat R, Shelton J, Hatcher RA: The Food and Drug Administration and medroxyprogesterone acetate. What are the issues? J Am Med Assoc 249:2922\u20132928, 1983.","journal-title":"J Am Med Assoc"},{"key":"BF01831473_CR11","first-page":"219","volume-title":"Steroid Receptors and Hormone-dependent Neoplasia","author":"EW Bergink","year":"1980","unstructured":"Bergink EW, Attia M, De Jager E: Effects of estradiol-17\u03b2 and progesterone on the mammary gland of the beagle dog: morphology and receptor levels in the cytosol fraction.In Wittliff JL, Dapunt O (eds) Steroid Receptors and Hormone-dependent Neoplasia. Masson USA, New York, 1980, pp 219\u2013222."},{"key":"BF01831473_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0041-008X(73)90054-9","volume":"24","author":"K Capel-Edwards","year":"1973","unstructured":"Capel-Edwards K, Hall DE, Fellowes KP, Vallance DK: Long-term administration of progesterone to the female beagle dog. Toxicol Appl Pharmacol 24:474\u2013488, 1973.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01831473_CR13","first-page":"228","volume-title":"The Correlation of Adverse Effects in Man with Observations in Animals","author":"MJ Tucker","year":"1971","unstructured":"Tucker MJ: Some effects of prolonged administration of a progestogen to dogs.In Baker SB (ed) The Correlation of Adverse Effects in Man with Observations in Animals. Excerpta Medica, Amsterdam, 1971, pp 228\u2013238."},{"key":"BF01831473_CR14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/jnci\/60.6.1351","volume":"60","author":"RC Giles","year":"1978","unstructured":"Giles RC, Kwapien RP, Geil RG, Casey HW: Mammary nodules in beagle dogs administered investigational oral contraceptive steroids. J Natl Cancer Inst 60:1351\u20131364, 1978.","journal-title":"J Natl Cancer Inst"},{"key":"BF01831473_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/icb.1962.17","volume":"40","author":"AG Jabara","year":"1962","unstructured":"Jabara AG: Induction of canine ovarian tumors by diethylstilbestrol and progesterone. Aust J Exp Biol Med Sci 40:139\u2013152, 1962.","journal-title":"Aust J Exp Biol Med Sci"},{"key":"BF01831473_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/icb.1962.33","volume":"40","author":"AG Jabara","year":"1962","unstructured":"Jabara AG: Some tissue changes in the dog following stilbestrol administration. Aust J Exp Biol Med Sci 40:293\u2013308, 1962.","journal-title":"Aust J Exp Biol Med Sci"},{"key":"BF01831473_CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0015-0282(16)43886-0","volume":"31","author":"DW Frank","year":"1979","unstructured":"Frank DW, Kirton KT, Murchison TE, Quinlan WJ, Coleman ME, Gilbertson TJ, Feenstra ES, Kimball FA: Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate for four years. Fert Steril 31:340\u2013346, 1979.","journal-title":"Fert Steril"},{"key":"BF01831473_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0015-0282(16)45741-9","volume":"36","author":"PW Concannon","year":"1981","unstructured":"Concannon PW, Spraker TR, Casey HW, Hansel W: Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult female beagle bitches. Fert Steril 36:373\u2013387, 1981.","journal-title":"Fert Steril"},{"issue":"Suppl 185","key":"BF01831473_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1530\/acta.0.075S074","volume":"75","author":"R Hill","year":"1974","unstructured":"Hill R, Dumas K: The use of dogs for studies of toxicity of contraceptive hormones. Acta Endocrinol (Kbh) 75 (Suppl 185):74\u201389, 1974.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0010-7824(79)80033-5","volume":"20","author":"S Beier","year":"1979","unstructured":"Beier S, Haase F, Kosub B, D\u00fcsterberg B, Elger W: The progestational activity of different gestagens used for human contraception in the beagle bitch. Contraception 20:533\u2013548, 1979.","journal-title":"Contraception"},{"key":"BF01831473_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0163-7258(79)90096-2","volume":"5","author":"F Neumann","year":"1979","unstructured":"Neumann F, Gr\u00e4f KJ: Some comparative endocrinopharmacological aspects and their relevance in the interpretation of adverse drug effects. Pharmac Ther 5:271\u2013286, 1979.","journal-title":"Pharmac Ther"},{"issue":"Suppl 1","key":"BF01831473_CR22","first-page":"27","volume":"125","author":"W Misdorp","year":"1991","unstructured":"Misdorp W: Progestagens and mammary tumours in dogs and cats. Acta Endocrinol (Kbh) 125(Suppl 1):27\u201331, 1991.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1097-0142(197008)26:2<419::AID-CNCR2820260225>3.0.CO;2-U","volume":"26","author":"R Schneider","year":"1970","unstructured":"Schneider R: Comparison of age, sex and incidence rates in human and canine breast cancer. Cancer 26:419\u2013426, 1970.","journal-title":"Cancer"},{"key":"BF01831473_CR24","first-page":"137","volume":"65","author":"RP Kwapien","year":"1980","unstructured":"Kwapien RP, Giles RC, Geil RG, Casey HW: Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids. J Natl Cancer Inst 65:137\u2013144, 1980.","journal-title":"J Natl Cancer Inst"},{"key":"BF01831473_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/01652176.1988.9694142","volume":"10","author":"W Misdorp","year":"1988","unstructured":"Misdorp W: Canine mammary tumours: protective effect of late ovariectomy and stimulating effects of progestins. Vet Quart 10:26\u201333, 1988.","journal-title":"Vet Quart"},{"key":"BF01831473_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.ge.16.120182.001421","volume":"16","author":"P Bentvelzen","year":"1982","unstructured":"Bentvelzen P: Interaction between host and viral genomes in mouse mammary tumors. Ann Rev Genet 16:273\u2013295, 1982.","journal-title":"Ann Rev Genet"},{"key":"BF01831473_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/019262338901700215","volume":"17","author":"RF McConnell","year":"1989","unstructured":"McConnell RF: Comparative aspects of contraceptive steroids: effects observed in rats. Toxicol Pathol 17:385\u2013388, 1989.","journal-title":"Toxicol Pathol"},{"key":"BF01831473_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01670031","volume":"48","author":"J Meites","year":"1980","unstructured":"Meites J: Relation of the neuroendocrine system to the development and growth of experimental mammary tumors. J Neural Transmission 48:25\u201342, 1980.","journal-title":"J Neural Transmission"},{"key":"BF01831473_CR29","first-page":"3415","volume":"45","author":"CW Welsch","year":"1985","unstructured":"Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415\u20133443, 1985.","journal-title":"Cancer Res"},{"key":"BF01831473_CR30","first-page":"927","volume":"74","author":"CJ Grubbs","year":"1985","unstructured":"Grubbs CJ, Farnell DR, Hill DR, McDonough KC: Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancers by pretreatment with 17\u03b2-estradiol and progesterone. J Natl Cancer Inst 74:927\u201331, 1985","journal-title":"J Natl Cancer Inst"},{"key":"BF01831473_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3835(86)90027-3","volume":"33","author":"C Lanari","year":"1986","unstructured":"Lanari C, Molinolo A, Pasqualina CD: Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB\/c female mice. Cancer Lett 33:215\u2013223, 1986.","journal-title":"Cancer Lett"},{"key":"BF01831473_CR32","first-page":"1399","volume":"8","author":"H Nagasawa","year":"1988","unstructured":"Nagasawa H, Sakagami N, Ohbayashi R, Yamamoto K, Petrow V: Effect of megestrol acetate or melengestrol acetate on preneoplastic and neoplastic mammary growth in mice. Anticancer Res 8:1399\u20131404, 1988.","journal-title":"Anticancer Res"},{"key":"BF01831473_CR33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bjc.1989.43","volume":"59","author":"IH Russo","year":"1989","unstructured":"Russo IH, Gimotty P, Dupuis M, Russo J: Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Br J Cancer 59:210\u2013216, 1989.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01805975","volume":"14","author":"IH Russo","year":"1989","unstructured":"Russo IH, Frederick J, Russo J: Hormone prevention of mammary carcinogenesis by norethynodrelmestranol. Breast Cancer Res Treat 14:43\u201356, 1989.","journal-title":"Breast Cancer Res Treat"},{"key":"BF01831473_CR35","first-page":"244","volume":"62","author":"J Russo","year":"1990","unstructured":"Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ: Biology of disease: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244\u2013278, 1990.","journal-title":"Lab Invest"},{"key":"BF01831473_CR36","first-page":"1247","volume":"8","author":"IH Russo","year":"1988","unstructured":"Russo IH, Russo J: Hormone prevention of mammary carcinogenesis: a new approach in anticancer research. Anticancer Res 8:1247\u20131264, 1988.","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"BF01831473_CR37","first-page":"7","volume":"125","author":"IH Russo","year":"1991","unstructured":"Russo IH, Russo J: Progestagens and mammary gland development: differentiation versus carcinogenesis. Acta Endocrinol (Kbh) 125 (Suppl 1):7\u201312, 1991.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR38","first-page":"1793","volume":"11","author":"W Misdorp","year":"1991","unstructured":"Misdorp W, Romijn A, Hart AAM: Feline mammary tumours: a case-control study of hormonal factors. Anticancer Res 11:1793\u20131798, 1991.","journal-title":"Anticancer Res"},{"key":"BF01831473_CR39","first-page":"213","volume":"131","author":"FA Tavassoli","year":"1988","unstructured":"Tavassoli FA, Casey HW, Norris HJ: The morphologic effects of synthetic reproductive steroids on the mammary gland of rhesus monkeys. Am J Pathol 131:213\u2013234, 1988.","journal-title":"Am J Pathol"},{"key":"BF01831473_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/diab.24.4.337","volume":"24","author":"JM Sloan","year":"1975","unstructured":"Sloan JM, Oliver IM: Progestogen-induced diabetes in the dog. Diabetes 24:337\u2013344, 1975.","journal-title":"Diabetes"},{"key":"BF01831473_CR41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/endo-106-4-1173","volume":"106","author":"PW Concannon","year":"1980","unstructured":"Concannon PW, Altszuler N, Hampshire J, Butler WR, Hansel W: Growth hormone, prolactin and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinology 106:1173\u20131177, 1980.","journal-title":"Endocrinology"},{"key":"BF01831473_CR42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1530\/acta.0.0980599","volume":"98","author":"JE Eigenmann","year":"1981","unstructured":"Eigenmann JE, Rijnberk A: Influence of medroxy-progesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. I. Studies in the ovariohysterectomized bitch. Acta Endocrinol (Kbh) 98:599\u2013602, 1981.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/030098588001700101","volume":"17","author":"MF Etreby El","year":"1980","unstructured":"El Etreby MF, M\u00fcller-Peddinghausen R, Bhargara AS, Fath El Bab MR, Gr\u00e4f KJ, Trautwein G: The role of the pituitary gland in spontaneous canine mammary tumorigenesis. Vet Pathol 17: 2\u201316, 1980.","journal-title":"Vet Pathol"},{"key":"BF01831473_CR44","first-page":"235","volume":"9","author":"GR Rutteman","year":"1989","unstructured":"Rutteman GR, Misdorp W, van den Brom WE, Rijnberk A: Anterior pituitary function in female dogs with mammary tumors: I. Growth hormone. Anticancer Res 9:235\u2013240, 1989.","journal-title":"Anticancer Res"},{"key":"BF01831473_CR45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/acta.0.1040167","volume":"104","author":"JE Eigenmann","year":"1983","unstructured":"Eigenmann JE, Eigenmann RY, Rijnberk A, van der Gaag I, Zapf J, Froesch ER: Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Kbh) 104:167\u2013176, 1983.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/acta.0.1140275","volume":"114","author":"GR Rutteman","year":"1987","unstructured":"Rutteman GR, Stolp R, Rijnberk A, Loeffler S, Bakker JA, Bevers MM, Meulenberg PMM, Eigenmann JE: Medroxy-progesterone acetate administration to ovariohysterectomized, oestradiolprimed beagle bitches. Effect on secretion of growth hormone, prolactin and cortisol. Acta Endocrinol (Kbh) 114:275\u2013282, 1987.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3181\/00379727-140-36458","volume":"140","author":"BL Baker","year":"1972","unstructured":"Baker BL, Eskin TA, Clapp HW: The effect of medroxyprogesterone on cells of the pituitary pars distalis. Proc Soc Exp Biol Med 140:357\u2013361, 1972.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF01831473_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/endo-109-1-99","volume":"109","author":"RC Winneker","year":"1981","unstructured":"Winneker RC, Parsons JA: Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors. Endocrinology 109:99\u2013105, 1981.","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"BF01831473_CR49","first-page":"42","volume":"125","author":"PJ Selman","year":"1991","unstructured":"Selman PJ, Mol JA, Rutteman GR, Rijnberk A: Progestins and growth hormone excess in the dog. Acta Endocrinol (Kbh) 125 Suppl 1:42\u201347, 1991.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(77)90295-2","volume":"128","author":"DR Mishell Jr","year":"1977","unstructured":"Mishell DR Jr, Kletzky OA, Brenner PF, Roy S, Nicoloff J: The effect of contraceptive steroids on hypothalamic-pituitary function. Am J Obstet Gynecol 128:60\u201374, 1977.","journal-title":"Am J Obstet Gynecol"},{"key":"BF01831473_CR51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1471-0528.1989.tb03352.x","volume":"96","author":"L Eriksson","year":"1989","unstructured":"Eriksson L, Frankenne F, Ed\u00e8n, Hennen G, Von Schoultz B: Growth hormone 24-h serum profiles during pregnancy \u2014 lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 96:949\u2013953, 1989.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF01831473_CR52","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/bjc.1988.266","volume":"58","author":"GR Rutteman","year":"1988","unstructured":"Rutteman GR, Misdorp W, Blankenstein MA, van den Brom WE: Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in nonmalignant and malignant states. Br J Cancer 58:594\u2013599, 1988.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(74)91482-2","volume":"ii","author":"I Souza De","year":"1974","unstructured":"De Souza I, Morgan L, Lewis UJ, Raggatt, PR, Salih H, Hobbs JR: Growth hormone dependence among human breast cancers. Lancet ii:182\u2013184, 1974.","journal-title":"Lancet"},{"key":"BF01831473_CR54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-2007-1013563","volume":"17","author":"JT Emerman","year":"1985","unstructured":"Emerman JT, Leahy M, Gout PW, Bruchovski N: Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17:421\u2013424, 1985.","journal-title":"Horm Metab Res"},{"key":"BF01831473_CR55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0010-7824(91)90004-Y","volume":"43","author":"JL Schlesselman","year":"1991","unstructured":"Schlesselman JL: Oral contraceptives and neoplasia of the uterine corpus. Contraception 43:557\u2013580, 1991.","journal-title":"Contraception"},{"key":"BF01831473_CR56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0010-7824(91)90003-X","volume":"43","author":"JL Stanford","year":"1991","unstructured":"Stanford JL: Oral contraceptives and neoplasia of the ovary. Contraception 43:543\u2013556, 1991.","journal-title":"Contraception"},{"key":"BF01831473_CR57","first-page":"166","volume-title":"Cancer Risks and Prevention","author":"MP Vessey","year":"1985","unstructured":"Vessey MP: Exogenous hormones.In Vessey MP, Gray M (eds) Cancer Risks and Prevention. Oxford Univ Press, Oxford, 1985, pp 166\u2013194."},{"key":"BF01831473_CR58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0010-7824(91)90005-Z","volume":"43","author":"LA Brinton","year":"1991","unstructured":"Brinton LA: Oral contraceptives and cervical neoplasia. Contraception 43:581\u2013596, 1991.","journal-title":"Contraception"},{"key":"BF01831473_CR59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"TJA Key","year":"1988","unstructured":"Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24:29\u201343, 1988.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01831473_CR60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/02841868909092320","volume":"28","author":"H Olsson","year":"1989","unstructured":"Olsson H: Oral contraceptives and breast cancer. A review. Acta Oncol 28:849\u2013863, 1989.","journal-title":"Acta Oncol"},{"key":"BF01831473_CR61","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19901201)66:11<2253::AID-CNCR2820661102>3.0.CO;2-G","volume":"66","author":"I Romieu","year":"1990","unstructured":"Romieu I, Berlin JA, Colditz G: Oral contraceptives and breast cancer. Review and meta-analysis. Cancer 66:2253\u20132263, 1990.","journal-title":"Cancer"},{"key":"BF01831473_CR62","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0010-7824(91)90006-2","volume":"43","author":"DB Thomas","year":"1991","unstructured":"Thomas DB: Oral contraceptives and breast cancer: review of the epidemiologic literature. Contraception 43:597\u2013642, 1991.","journal-title":"Contraception"},{"issue":"Suppl 1","key":"BF01831473_CR63","first-page":"13","volume":"125","author":"FE Leeuwen Van","year":"1991","unstructured":"Van Leeuwen FE: Epidemiologic aspects of exogenous progestagens in relation to their role in the pathogenesis of human breast cancer. Acta Endocrinol (Kbh) 125(Suppl 1):13\u201326, 1991.","journal-title":"Acta Endocrinol"},{"key":"BF01831473_CR64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(16)54647-0","volume":"56","author":"KF McGonigle","year":"1991","unstructured":"McGonigle KF, Huggins GR: Oral contraceptives and breast disease. Fert Steril 56:799\u2013819, 1991.","journal-title":"Fert Steril"},{"key":"BF01831473_CR65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jech.40.4.289","volume":"40","author":"K McPherson","year":"1986","unstructured":"McPherson K, Coope PA, Vessey MP: Early oral contraceptive use and breast cancer: theoretical effects of latency. J Epidemiol Commun Health 40:289\u2013294, 1986.","journal-title":"J Epidemiol Commun Health"},{"key":"BF01831473_CR66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/014107688407700514","volume":"77","author":"GIM Swyer","year":"1984","unstructured":"Swyer GIM: Determination of progestational potency: A review. J Royal Soc Med 77:406\u2013409, 1984.","journal-title":"J Royal Soc Med"},{"key":"BF01831473_CR67","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1001\/jama.1988.03720120032031","volume":"259","author":"JJ Schlesselman","year":"1988","unstructured":"Schlesselman JJ, Stadel BV, Murray P, Lai S: Breast cancer in relation to early use of oral contraceptives. No evidence of a latent effect. J Am Med Assoc 259:1828\u20131833, 1988.","journal-title":"J Am Med Assoc"},{"key":"BF01831473_CR68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/bjc.1990.23","volume":"61","author":"The WHO Collaborative Study of Neoplasia and Steroid Contraceptives","year":"1990","unstructured":"The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 61:110\u2013119, 1990.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR69","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/bjc.1988.285","volume":"58","author":"CR Kay","year":"1988","unstructured":"Kay CR, Hannaford PC: Breast cancer and the pill \u2014 A further report from the Royal College of General Practitioners' oral contraception study. Br J Cancer 58:675\u2013680, 1988.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.299.6702.759","volume":"299","author":"C Paul","year":"1989","unstructured":"Paul C, Skegg DCG, Spears GFS: Depot medroxyprogesterone (Depo-provera) and risk of breast cancer. Br Med J 299:759\u2013762, 1989.","journal-title":"Br Med J"},{"key":"BF01831473_CR71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0025-6196(12)60244-4","volume":"59","author":"RE Scott","year":"1984","unstructured":"Scott RE, Wille JJ Jr, Wier ML: Mechanism for the initiation and promotion of carcinogenesis: a review and a new concept. Mayo Clin Proc 59: 107\u2013117, 1984.","journal-title":"Mayo Clin Proc"},{"key":"BF01831473_CR72","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/1097-0142(197706)39:6<2734::AID-CNCR2820390661>3.0.CO;2-U","volume":"39","author":"RD Cardiff","year":"1977","unstructured":"Cardiff RD, Wellings SR, Faulkin LJ: Biology of breast neoplasia. Cancer 39:2734\u20132746, 1977.","journal-title":"Cancer"},{"key":"BF01831473_CR73","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1987.296","volume":"56","author":"M Nielsen","year":"1987","unstructured":"Nielsen M, Thomson JL, Primdahl S, Dyreborg U, Andersen JA: Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814\u2013819, 1987.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293\u2013297, 1989.","journal-title":"N Engl J Med"},{"key":"BF01831473_CR75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","volume":"151","author":"WD Dupont","year":"1991","unstructured":"Dupont WD, Page DL: Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 151:67\u201372, 1991.","journal-title":"Arch Intern Med"},{"key":"BF01831473_CR76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","volume":"11","author":"CL Clarke","year":"1990","unstructured":"Clarke CL, Sutherland RL: Progestin regulation of cellular proliferation. Endocrine Rev 11:266\u2013301, 1990.","journal-title":"Endocrine Rev"},{"key":"BF01831473_CR77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0010-7824(91)90002-W","volume":"43","author":"RJB King","year":"1991","unstructured":"King RJB: Biology of female sex hormone action in relation to contraceptive agents and neoplasia. Contraception 43:527\u2013542, 1991.","journal-title":"Contraception"},{"key":"BF01831473_CR78","first-page":"246","volume":"48","author":"BE Henderson","year":"1988","unstructured":"Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 48:246\u2013253, 1988.","journal-title":"Cancer Res"},{"key":"BF01831473_CR79","first-page":"627","volume":"8","author":"B Zumoff","year":"1988","unstructured":"Zumoff B: Hormonal profiles in women with breast cancer (Review). Anticancer Res 8:627\u2013636, 1988.","journal-title":"Anticancer Res"},{"key":"BF01831473_CR80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-1110(90)90018-7","volume":"238","author":"JG Liehr","year":"1990","unstructured":"Liehr JG: Genotoxic effects of estrogens. Mutation Res 238:269\u2013276, 1990.","journal-title":"Mutation Res"},{"key":"BF01831473_CR81","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1073\/pnas.83.14.5301","volume":"83","author":"JG Liehr","year":"1986","unstructured":"Liehr JG, Avitts TA, Randerath E, Randerath K: Estrogen-induced endogenous DNA adduction: Possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 83:5301\u20135305, 1986.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01831473_CR82","first-page":"573","volume":"5","author":"HL Bradlow","year":"1986","unstructured":"Bradlow HL, Hershcopf RE, Fishman JF: Oestradiol 16\u03b1-hydroxylase: a risk marker for breast cancer. Cancer Surv 5:573\u2013583, 1986.","journal-title":"Cancer Surv"},{"key":"BF01831473_CR83","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/edrv-11-4-524","volume":"11","author":"JJ Li","year":"1990","unstructured":"Li JJ, Li SA: Estrogen carcinogenesis in hamster tissues: a critical review. Endocrine Rev 11:524\u2013531, 1990.","journal-title":"Endocrine Rev"},{"key":"BF01831473_CR84","first-page":"3814","volume":"43","author":"T Tsutsui","year":"1983","unstructured":"Tsutsui T, Maizumi H, McLachlan JA, Barrett JC: Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. Cancer Res 43:3814\u20133821, 1983.","journal-title":"Cancer Res"},{"key":"BF01831473_CR85","first-page":"123","volume":"88","author":"B Epe","year":"1990","unstructured":"Epe B, Harttig U, Stopper H, Metzler M: Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneuploidy induction and neoplastic cell transformation. Environ Health Perspect 88:123\u2013127, 1990.","journal-title":"Environ Health Perspect"},{"key":"BF01831473_CR86","first-page":"635","volume":"5","author":"SH Moolgavkar","year":"1986","unstructured":"Moolgavkar SH: Hormones and multistage carcinogenesis. Cancer Surv 5:635\u2013648, 1986.","journal-title":"Cancer Surv"},{"key":"BF01831473_CR87","first-page":"33","volume":"4","author":"GR Rutteman","year":"1990","unstructured":"Rutteman GR: Hormones and mammary tumour disease in the female dog: an update. In Vivo 4:33\u201340, 1990.","journal-title":"In Vivo"},{"key":"BF01831473_CR88","first-page":"471","volume":"49","author":"G Secreto","year":"1989","unstructured":"Secreto G, Toniolo P, Pisani P, Recchione C, Cavalleri A, Fariselli G, Totis A, Di Pietro S, Berrino F: Androgens and breast cancer in premenopausal women. Cancer Res 49:471\u2013476, 1989.","journal-title":"Cancer Res"},{"key":"BF01831473_CR89","first-page":"20","volume-title":"Fibrocystic disease of the breast. A revisit and new perspectives","author":"A Angeli","year":"1984","unstructured":"Angeli A, Dogliotti L, Faggiuolo R, Orlandi F, Bussolati G: Fibrocystic disease of the breast. A revisit and new perspectives. Excerpta Medica, Amsterdam, 1984, pp 20\u201331."},{"key":"BF01831473_CR90","unstructured":"Going JJ, Anderson TJ, Battersby S, MacIntyre CCA: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130:193\u2013204."},{"key":"BF01831473_CR91","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/58.5.1263","volume":"58","author":"JRW Masters","year":"1977","unstructured":"Masters JRW, Drife JO, Scarisbrick JJ: Cyclic variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 58:1263\u20131265, 1977.","journal-title":"J Natl Cancer Inst"},{"key":"BF01831473_CR92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bjc.1988.185","volume":"58","author":"CS Potten","year":"1988","unstructured":"Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58:163\u2013170, 1988.","journal-title":"Br J Cancer"},{"key":"BF01831473_CR93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ijc.2910480209","volume":"48","author":"G Williams","year":"1991","unstructured":"Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Potten CS: Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48:206\u2013210, 1991.","journal-title":"Int J Cancer"},{"key":"BF01831473_CR94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01807330","volume":"8","author":"P Mauvais-Jarvis","year":"1986","unstructured":"Mauvais-Jarvis P, Kuttenn F, Gompel A: Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 8:179\u2013188, 1986.","journal-title":"Breast Cancer Res Treat"},{"key":"BF01831473_CR95","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(89)80003-6","volume":"20","author":"TJ Anderson","year":"1989","unstructured":"Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ: Oral contraceptive use influences resting breast proliferation. Hum Pathol 20: 1139\u20131144, 1989.","journal-title":"Hum Pathol"},{"key":"BF01831473_CR96","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/edrv-11-4-494","volume":"11","author":"W Imagawa","year":"1990","unstructured":"Imagawa W, Bandyopadhyay, Nandi S: Regulation of mammary epithelial cell growth in mice and rats. Endocrine Rev 11:494\u2013523, 1990.","journal-title":"Endocrine Rev"},{"key":"BF01831473_CR97","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1210\/endo-127-5-2183","volume":"127","author":"S Wang","year":"1990","unstructured":"Wang S, Counterman LJ, Haslam SZ: Progesterone action in normal mouse mammary gland. Endocrinology 127:2183\u20132189, 1990.","journal-title":"Endocrinology"},{"key":"BF01831473_CR98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-75948-2_2","volume-title":"Endocrine Therapy of Breast Cancer IV. European School of Oncology Monograph","author":"RJB King","year":"1990","unstructured":"King RJB: Role of oestrogen and progestin in human mammary carcinogenesis.In Goldhirsch A (ed) Endocrine Therapy of Breast Cancer IV. European School of Oncology Monograph, Springer Verlag, Berlin, 1990, pp 3\u20138."},{"key":"BF01831473_CR99","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1097-0142(19870115)59:2<281::AID-CNCR2820590218>3.0.CO;2-A","volume":"59","author":"SM Longman","year":"1987","unstructured":"Longman SM, Buehring GC: In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 59:281\u2013287, 1987.","journal-title":"Cancer"},{"key":"BF01831473_CR100","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1210\/mend-5-8-1120","volume":"5","author":"MH Jeng","year":"1991","unstructured":"Jeng MH, Jordan VC: Growth stimulation and differential regulation of transforming growth factor-\u03b21 (TGF\u03b21), TGF\u03b22, and TGF\u03b23 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Mol Endocrinol 5:1120\u20131128, 1991.","journal-title":"Mol Endocrinol"},{"key":"BF01831473_CR101","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","volume":"249","author":"SM Cohen","year":"1990","unstructured":"Cohen SM, Ellwein LB: Cell proliferation in carcinogenesis. Science 249:1007\u20131011, 1990.","journal-title":"Science"},{"key":"BF01831473_CR102","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(91)91498-J","volume":"338","author":"WHO Collaborative Study of Neoplasia and Steroid Contraceptives","year":"1991","unstructured":"WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Breast cancer and depot-medroxy-progesterone acetate: a multinational study. Lancet 338:833\u2013838, 1991.","journal-title":"Lancet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01831473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01831473\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01831473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T15:29:42Z","timestamp":1683127782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01831473"}},"subtitle":["Insights from animal studies"],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":102,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF01831473"],"URL":"https:\/\/doi.org\/10.1007\/bf01831473","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}